Skip to search formSkip to main contentSkip to account menu

ProMACE-MOPP protocol

Known as: CTX/DOX/MTX/NM/PCB/PRED/VCR/VP-16, ProMACE-MOPP, ProMACE/MOPP 
A chemotherapy combination consisting of cyclophosphamide, doxorubicin, etoposide, mechlorethamine, methotrexate, prednisone, procarbazine, and… 
National Institutes of Health

Related topics

Related topics

13 relations

Broader (7)

Antineoplastic Combined Chemotherapy ProtocolsCyclophosphamideEtoposideMechlorethamine
DoxorubicinDoxorubicin HydrochlorideMechlorethamine hydrochloridePrednisone

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2007
2007
Linfoma de Hodkin en Chile: Experiencia de 15 años del Programa Nacional de Cáncer del Adulto
Median age was 37 years (15-84). Nodularsclerosis and mixed cellularity were equally expressed. Advanced stages (III & IV) were… 
2004
2004
ChlVPP/ABVVP, a first line ‘hybrid’ combination chemotherapy for advanced Hodgkin's lymphoma: a retrospective analysis
We retrospectively analysed toxicities and clinical results of 61 Hodgkin's lymphoma patients treated with chlorambucil… 
1998
1998
Effects of recombinant granulocyte colony-stimulating factor (G-CSF) in patients treated with ProMACE-CytaBOM for HIV-related non-Hodgkin's lymphoma (NHL).
BACKGROUND AND OBJECTIVE The use of hematopoietic growth factors in association with chemotherapy in human immunodeficiency virus… 
1997
1997
Durable remission after aggressive chemotherapy for post-cardiac transplant lymphoproliferation.
A frequently fatal complication of organ transplantation, post-transplant lymphoproliferative disorder (PTLD) develops in 2%-6… 
1996
1996
PROMACE-MOPP and intrathecal chemotherapy for CNS lymphomas
We conducted a Phase II study of PROMACE-MOPP and intrathecal (IT) therapy followed by cranial radiation in 7 patients (4 male, 3… 
1995
1995
Advanced diffuse non‐Hodgkin's lymphoma. Analysis of prognostic factors by the international index and by lactic dehydrogenase in an intergroup study
Background. Recent data have suggested that there are no differences among various anthracycline‐based chemotherapy regimens… 
1992
1992
Salvage therapy with ProMACE-MOPP followed by intensive chemoradiotherapy and autologous bone marrow transplantation for patients with non-Hodgkin's lymphoma who failed to respond to first-line CHOP.
PURPOSE We used alternative chemotherapy immediately followed in early-response patients by high-dose chemoradiotherapy and… 
1988
1988
Southwest Oncology Group clinical trials for intermediate- and high-grade non-Hodgkin's lymphomas.
The Southwest Oncology Group (SWOG) began testing doxorubicin-containing combination chemotherapy in 1972 using the… 
1979
1979
A comparison between combination chemotherapy and total body irradiation plus combination chemotherapy in non‐Hodgkin's lymphoma
Thirty‐nine untreated patients with either lymphocytic or nodular mixed/nodular histiocytic non‐Hodgkin's lymphoma, stage II‐IV… 
1977
1977
Successful chemotherapy of advanced non-Hodgkin's lymphoma after relapse following total body irradiation.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)